Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PRTA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
26 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 5 days ago
Red flags: 0
188 filers reported a long position in PRTA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $70.5M | 7.2M | -4.7% |
| Rubric Capital Management LP | $49M | 5M | Unchanged |
| BlackRock, Inc. | $47.7M | 4.9M | +4.8% |
| STATE STREET CORP | $23.4M | 2.4M | +23.5% |
| ACADIAN ASSET MANAGEMENT LLC | $19.7M | 2M | +29.9% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $16.2M | 1.7M | +14.2% |
| D. E. Shaw & Co., Inc. | $15.8M | 1.6M | -8.6% |
| ADAR1 Capital Management, LLC | $15.2M | 1.6M | -1.7% |
| TWO SIGMA INVESTMENTS, LP | $12.4M | 1.3M | +4.9% |
| Palo Alto Investors LP | $11.2M | 1.1M | -5.4% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.